Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program
about
TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations.A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.The Efficacy and Risk Profile of c-Met inhibitors in Non-small Cell Lung Cancer: a Meta-analysis.Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.
P2860
Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@ast
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@en
type
label
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@ast
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@en
prefLabel
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@ast
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@en
P2093
P2860
P1433
P1476
Safety of Onartuzumab in Patie ...... tuzumab Clinical Trial Program
@en
P2093
Alison Cardenas
Daniel Koralek
Jessie Hsu
Mark Merchant
Patricia Luhn
Peter Hawkins
Roland Morley
See-Chun Phan
Virginia Paton
P2860
P304
P356
10.1371/JOURNAL.PONE.0139679
P407
P577
2015-10-07T00:00:00Z